Target intelligence / Profile preview

Vagal afferent nerve

Molecular classification
Other
01

Overview

Vagal afferent nerves are the sensory fibers of the vagus nerve, comprising approximately 80-90% of its axonal content. Their cell bodies reside in the nodose and jugular ganglia, and their peripheral endings innervate visceral organs such as the heart, lungs, and gastrointestinal tract. Functionally, these fibers detect mechanical, chemical, hormonal, and immune-related stimuli and project centrally to the nucleus of the solitary tract and dorsal vagal complex of the brainstem, where they play key roles in visceral homeostasis, interoception, and autonomic regulation. Vagal afferent signaling contributes to regulation of heart rate, gastrointestinal motility, immune modulation, and even mood states. Disruption of vagal afferent pathways can lead to cardiovascular instability, gastrointestinal dysfunction, and altered emotional behavior. While not a canonical molecular therapeutic target (such as a receptor or enzyme), vagal afferent nerve signaling is the subject of neuromodulatory therapies (such as vagus nerve stimulation) aimed at treating epilepsy, depression, and inflammatory disorders[1][2][3]. "Vagal afferent nerve signaling" refers to a physiological signaling process (not a discrete molecule, receptor, or druggable target) and is therefore not a canonical therapeutic target, but a physiological pathway[1][2][3].

Other names
Vagal afferent fiberVagal sensory neuronVagal afferent
02

Mechanism of action

Neuromodulation through electrical/radiofrequency stimulation (e.g., vagus nerve stimulation)

03

Biological functions

Signal transductionInteroceptionAutonomic regulationImmune response
04

Disease associations

Cardiovascular diseaseGastrointestinal disorderMood disorderNeurodegenerative diseaseOther
05

Safety considerations

Off-target autonomic effectsBradycardiaGastrointestinal disturbancesRespiratory effects
06

Interacting drugs

None (individual drugs do not target "vagal afferent signaling" directly, but some therapies modulate this pathway, e.g., electrical stimulation)

Beyond the preview

Go deeper on Vagal afferent nerve.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vagal afferent nerve.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call